+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biologic"

From
Single-use Technologies for Biopharmaceuticals Market - Product Thumbnail Image

Single-use Technologies for Biopharmaceuticals Market

  • Report
  • November 2024
  • 207 Pages
  • Global
From
Biopharmaceutical Market Outlook to 2029 - Product Thumbnail Image

Biopharmaceutical Market Outlook to 2029

  • Report
  • September 2024
  • 97 Pages
  • Global
From
From
Markets for Media, Sera and Reagents in Biotechnology - Product Thumbnail Image

Markets for Media, Sera and Reagents in Biotechnology

  • Report
  • March 2025
  • 152 Pages
  • Global
From
Synthetic Biology: Global Markets - Product Thumbnail Image

Synthetic Biology: Global Markets

  • Report
  • August 2024
  • 137 Pages
  • Global
From
From
Loading Indicator

The biologic market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs. Biologic drugs are made from living organisms, such as proteins, nucleic acids, and cells, and are used to treat a variety of diseases. These drugs are typically more complex and expensive to produce than traditional small-molecule drugs. The biologic market is highly competitive, with many companies vying for market share. The biologic market is divided into two main segments: therapeutic biologics and biosimilars. Therapeutic biologics are drugs that are developed to treat a specific disease or condition, while biosimilars are drugs that are similar to existing biologic drugs but are not identical. Some of the major players in the biologic market include Amgen, Biogen, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development, production, and marketing of biologic drugs. Show Less Read more